Autotransfusion System Market by Type (Autotransfusion Accessories, Autotransfusion Products), Application (Cardiac Surgeries, Organ Transplantation, Orthopedic Surgeries), End User - Global Forecast 2024-2030
Autotransfusion System Market by Type (Autotransfusion Accessories, Autotransfusion Products), Application (Cardiac Surgeries, Organ Transplantation, Orthopedic Surgeries), End User - Global Forecast 2024-2030
The Autotransfusion System Market size was estimated at USD 532.52 million in 2023 and expected to reach USD 575.30 million in 2024, at a CAGR 8.18% to reach USD 923.65 million by 2030.
Autotransfusion systems are medical devices designed for collecting, processing, and reinfusion of the patient's own blood. This process entails collecting blood that has been lost during surgery or trauma, washing and filtering it, and then returning the cleaned blood to the patient. By using the patient's own blood, the risk of transfusion-related complications, such as allergic reactions or transmission of infectious diseases, is significantly reduced. The adoption of autotransfusion systems is increasing to mitigate the pressure on blood bank resources, particularly in times of scarcity or when matching blood types are in short supply. In addition, autotransfusion may be more cost-effective by decreasing the need for donated blood products, which require rigorous testing and storage procedures. The rise in surgical procedures, including cardiovascular, orthopedic, gynecological, and trauma surgeries, makes autotransfusion systems a versatile tool in the operating room. However, stringent regulatory approvals and limited availability of skilled professionals to operate autotransfusion systems limit the product penetration worldwide. Nevertheless, technological advancements in autotransfusion systems that improve efficiency and safety with ongoing investments in healthcare infrastructure are increasing the adoption of autotransfusion systems.
Regional Insights
The Americas represents a highly developing autotransfusion systems market due to the high volume of surgical procedures that require blood transfusions, a strong preference for technologically advanced systems, and investments in innovation and research within the sector. The regional healthcare system prioritizes patient safety and cost-efficiency, leading to a steady need for autotransfusion systems, particularly within the public health sector. In the European Union, the autotransfusion systems market is driven by a well-established healthcare sector and an increasing number of surgeries. Consumers prefer devices that align with EU medical device regulations, emphasizing safety and efficacy. The growing interest in the autotransfusion system in the Middle East and Africa is due to the increasing number of medical tourists and the development of healthcare infrastructure. Asia-Pacific’s rapidly growing healthcare sector has prompted significant interest in autotransfusion systems, with the government supporting research and innovation through investments. A keen interest in affordable medical devices and ongoing health initiatives encourage domestic production and research to reduce imports and make autotransfusion systems more accessible to healthcare providers across the Asia-Pacific region.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Autotransfusion System Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Increasing Number of Surgical and Transplant Procedures
Concern Associated with Blood Safety and Availability
Functional and Operational Benefits Associated with Autotransfusion System
Market Restraints
High Cost and Limited Availability of Trained Perfusionists and Surgical Technicians
Market Opportunities
Potential Utilization of Autotransfusion Systems in Hemothorax Treatments
Development of Innovative Autotransfusion Devices
Market Challenges
Health Risks Associated with the Autotransfusion Systems
Market Segmentation Analysis
Type: Wide availability of autotransfusion products capable of performing intraoperative and postoperative blood salvage
Application: Growing applicability of autotransfusion systems in cardiac surgeries
End User: Significant penetration of autotransfusion systems in emergency rooms
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Autotransfusion System Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Autotransfusion System Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
TEDCO Announces Investment into Sisu Global Health
TEDCO, Maryland's catalyst for innovation and entrepreneurship, bolstered Sisu Global Health with a USD 100,000 Inclusion Fund investment. This Baltimore-based company has innovated Hemafuse, a pioneering autotransfusion device destined to revolutionize emergency medical care by allowing the retransfusion of a patient's blood collected from internal bleeding during surgery.
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
Teleflex Incorporated received FDA clearance for its QuikClot Control+ Hemostatic Device, broadening its application to include mild to moderate bleeding in various cardiac surgeries and managing bleeding on bone surfaces post-sternotomy. This regulatory update permits healthcare professionals to employ the QuikClot Control+ across a full spectrum of cardiac surgical procedures, addressing a significant portion of the 600,000 open cardiothoracic operations conducted annually in the U.S.
Haemonetics Introduces Next Generation Intelligent Control Software for Cell Saver Elite+ Autotransfusion System
Haemonetics Corporation announced that the U.S. FDA has granted 510(k) clearance for the next-generation Intelligent Control software for their Cell Saver Elite+ Autotransfusion System. This software upgrade introduces over 50 automation improvements that revolutionize operational simplicity and efficiency, culminating in an unrivaled user experience.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Autotransfusion System Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Autotransfusion System Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Carolina Autotransfusion, Inc., Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Getinge AB, Global Blood Resources, LLC, Grifols, S.A., Haemonetics Corporation, i-SEP, Keystone Perfusion, Livanova PLC, Medtronic PLC, ProCell Surgical Inc., Redax S.p.A., Sarstedt AG & Co. KG, Sisu Global Health, SpecialtyCare, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Autotransfusion System Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Autotransfusion Accessories
Autotransfusion Products
Dual-Mode Autotransfusion Systems
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Application
Cardiac Surgeries
Organ Transplantation
Orthopedic Surgeries
Trauma Procedures
End User
Ambulatory Surgical Centers
Emergency Rooms
Hospitals
Nursing Homes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Number of Surgical and Transplant Procedures
5.1.1.2. Concern Associated with Blood Safety and Availability
5.1.1.3. Functional and Operational Benefits Associated with Autotransfusion System
5.1.2. Restraints
5.1.2.1. High Cost and Limited Availability of Trained Perfusionists and Surgical Technicians
5.1.3. Opportunities
5.1.3.1. Potential Utilization of Autotransfusion Systems in Hemothorax Treatments
5.1.3.2. Development of Innovative Autotransfusion Devices
5.1.4. Challenges
5.1.4.1. Health Risks Associated with the Autotransfusion Systems
5.2. Market Segmentation Analysis
5.2.1. Type: Wide availability of autotransfusion products capable of performing intraoperative and postoperative blood salvage
5.2.2. Application: Growing applicability of autotransfusion systems in cardiac surgeries
5.2.3. End User: Significant penetration of autotransfusion systems in emergency rooms
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Autotransfusion System Market, by Type
6.1. Introduction
6.2. Autotransfusion Accessories
6.3. Autotransfusion Products
7. Autotransfusion System Market, by Application
7.1. Introduction
7.2. Cardiac Surgeries
7.3. Organ Transplantation
7.4. Orthopedic Surgeries
7.5. Trauma Procedures
8. Autotransfusion System Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Emergency Rooms
8.4. Hospitals
8.5. Nursing Homes
9. Americas Autotransfusion System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Autotransfusion System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Autotransfusion System Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. TEDCO Announces Investment into Sisu Global Health
12.3.2. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
12.3.3. Haemonetics Introduces Next Generation Intelligent Control Software for Cell Saver Elite+ Autotransfusion System